Mobile

Study of the efficacy, safety and tolerability of repeated administration of eye drops containing regorafenib in newly diagnosed patients with "wet" or neovascular ("new blood vessel growth") Age-Rel...

Mise à jour : Il y a 5 ans
Référence : EUCTR2012-003763-22

Study of the efficacy, safety and tolerability of repeated administration of eye drops containing regorafenib in newly diagnosed patients with "wet" or neovascular ("new blood vessel growth") Age-Related Macular Degeneration (wet AMD). Kombinovaná studie fáze IIa/IIb účinnosti, bezpečnosti a snášenlivosti opakovaných dávek očních kapek regorafenibu u dosud neléčených subjektů s věkem podmíněnou neovaskulární makulární degenerací

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Assess the effect of treatment with regorafenib eye drops on visual acuity at Study Week 4 and at Study Week 12 in subjects with subfoveal choroidal neovascularization due to age related macular degeneration. For Part B: in addition, explore an optimal dosing regimen

Critère d'inclusion

  • Neovascular Age-related macular degeneration

Liens